Skip to main content
NCBI home page
Biochemical Journal logoLink to Biochemical Journal
. 2003 Oct 1;375(Pt 1):17–22. doi: 10.1042/BJ20031059

Identification of a novel Na+- and Cl--coupled transport system for endogenous opioid peptides in retinal pigment epithelium and induction of the transport system by HIV-1 Tat.

Huankai Hu 1, Seiji Miyauchi 1, Christy C Bridges 1, Sylvia B Smith 1, Vadivel Ganapathy 1
PMCID: PMC1223675  PMID: 12924983

Abstract

The endogenous opioid peptides enkephalins, dynorphins and endorphins consist of five or more amino acids. These peptides participate in a multitude of biological functions in mammalian cells by interacting with different subtypes of opiate receptors located on the plasma membrane and in the nucleus. Here we report on the identification of a new peptide transport system in the human retinal pigment epithelial (RPE) cells that transports a variety of endogenous opioid peptides with high affinity. We identified this novel, hitherto unrecognized, transport system when we were analysing the differential effects of Tat, the transacting factor encoded by HIV-1, on various transport processes in RPE cells. This transport system is markedly induced by Tat. This opioid transport system is energized by transmembrane Na+ and Cl- gradients and is distinct from any of the previously identified transport systems for opioid peptides in mammalian cells. Free amino acids, dipeptides, tripeptides and non-peptide opiate receptor antagonists are excluded by this newly identified transport system. The affinities of endogenous opioid peptides for this system are in the range of 0.4-40 microM. The identification of the high-affinity Na+- and Cl--coupled transport system in mammalian cells that is specific for endogenous opioid peptides and is induced by HIV-1 Tat is of significance not only to the biology of opioid peptides but also to the pathology of HIV-1 infection in humans.

Full Text

The Full Text of this article is available as a PDF (137.1 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Banks W. A., Kastin A. J., Fischman A. J., Coy D. H., Strauss S. L. Carrier-mediated transport of enkephalins and N-Tyr-MIF-1 across blood-brain barrier. Am J Physiol. 1986 Oct;251(4 Pt 1):E477–E482. doi: 10.1152/ajpendo.1986.251.4.E477. [DOI] [PubMed] [Google Scholar]
  2. Banks W. A., Kastin A. J., Michals E. A. Tyr-MIF-1 and Met-enkephalin share a saturable blood-brain barrier transport system. Peptides. 1987 Sep-Oct;8(5):899–903. doi: 10.1016/0196-9781(87)90078-7. [DOI] [PubMed] [Google Scholar]
  3. Banks W. A., Kastin A. J. Peptide transport systems for opiates across the blood-brain barrier. Am J Physiol. 1990 Jul;259(1 Pt 1):E1–10. doi: 10.1152/ajpendo.1990.259.1.E1. [DOI] [PubMed] [Google Scholar]
  4. Cattori V., van Montfoort J. E., Stieger B., Landmann L., Meijer D. K., Winterhalter K. H., Meier P. J., Hagenbuch B. Localization of organic anion transporting polypeptide 4 (Oatp4) in rat liver and comparison of its substrate specificity with Oatp1, Oatp2 and Oatp3. Pflugers Arch. 2001 Nov;443(2):188–195. doi: 10.1007/s004240100697. [DOI] [PubMed] [Google Scholar]
  5. Chaturvedi K., Christoffers K. H., Singh K., Howells R. D. Structure and regulation of opioid receptors. Biopolymers. 2000;55(4):334–346. doi: 10.1002/1097-0282(2000)55:4<334::AID-BIP1006>3.0.CO;2-S. [DOI] [PubMed] [Google Scholar]
  6. Daniel H. Function and molecular structure of brush border membrane peptide/H+ symporters. J Membr Biol. 1996 Dec;154(3):197–203. doi: 10.1007/s002329900144. [DOI] [PubMed] [Google Scholar]
  7. Gallo R. C. Tat as one key to HIV-induced immune pathogenesis and Tat (correction of Pat) toxoid as an important component of a vaccine. Proc Natl Acad Sci U S A. 1999 Jul 20;96(15):8324–8326. doi: 10.1073/pnas.96.15.8324. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Gao B., Hagenbuch B., Kullak-Ublick G. A., Benke D., Aguzzi A., Meier P. J. Organic anion-transporting polypeptides mediate transport of opioid peptides across blood-brain barrier. J Pharmacol Exp Ther. 2000 Jul;294(1):73–79. [PubMed] [Google Scholar]
  9. Gaynor R. B. Regulation of HIV-1 gene expression by the transactivator protein Tat. Curr Top Microbiol Immunol. 1995;193:51–77. doi: 10.1007/978-3-642-78929-8_3. [DOI] [PubMed] [Google Scholar]
  10. Hambrook J. M., Morgan B. A., Rance M. J., Smith C. F. Mode of deactivation of the enkephalins by rat and human plasma and rat brain homogenates. Nature. 1976 Aug 26;262(5571):782–783. doi: 10.1038/262782a0. [DOI] [PubMed] [Google Scholar]
  11. Hauser M., Donhardt A. M., Barnes D., Naider F., Becker J. M. Enkephalins are transported by a novel eukaryotic peptide uptake system. J Biol Chem. 2000 Feb 4;275(5):3037–3041. doi: 10.1074/jbc.275.5.3037. [DOI] [PubMed] [Google Scholar]
  12. Inui K., Terada T. Dipeptide transporters. Pharm Biotechnol. 1999;12:269–288. doi: 10.1007/0-306-46812-3_10. [DOI] [PubMed] [Google Scholar]
  13. Kieffer Brigitte L., Gavériaux-Ruff Claire. Exploring the opioid system by gene knockout. Prog Neurobiol. 2002 Apr;66(5):285–306. doi: 10.1016/s0301-0082(02)00008-4. [DOI] [PubMed] [Google Scholar]
  14. Kullak-Ublick G. A., Ismair M. G., Stieger B., Landmann L., Huber R., Pizzagalli F., Fattinger K., Meier P. J., Hagenbuch B. Organic anion-transporting polypeptide B (OATP-B) and its functional comparison with three other OATPs of human liver. Gastroenterology. 2001 Feb;120(2):525–533. doi: 10.1053/gast.2001.21176. [DOI] [PubMed] [Google Scholar]
  15. Leibach F. H., Ganapathy V. Peptide transporters in the intestine and the kidney. Annu Rev Nutr. 1996;16:99–119. doi: 10.1146/annurev.nu.16.070196.000531. [DOI] [PubMed] [Google Scholar]
  16. Ryder S. W., Eng J. Radioimmunoassay of leucine-enkephalin-like substance in human and canine plasma. J Clin Endocrinol Metab. 1981 Feb;52(2):367–369. doi: 10.1210/jcem-52-2-367. [DOI] [PubMed] [Google Scholar]
  17. Thomas S. A., Abbruscato T. J., Hruby V. J., Davis T. P. The entry of [D-penicillamine2,5]enkephalin into the central nervous system: saturation kinetics and specificity. J Pharmacol Exp Ther. 1997 Mar;280(3):1235–1240. [PubMed] [Google Scholar]
  18. Williams S. A., Abbruscato T. J., Hruby V. J., Davis T. P. Passage of a delta-opioid receptor selective enkephalin, [D-penicillamine2,5] enkephalin, across the blood-brain and the blood-cerebrospinal fluid barriers. J Neurochem. 1996 Mar;66(3):1289–1299. doi: 10.1046/j.1471-4159.1996.66031289.x. [DOI] [PubMed] [Google Scholar]
  19. Zagon Ian S., Verderame Michael F., McLaughlin Patricia J. The biology of the opioid growth factor receptor (OGFr). Brain Res Brain Res Rev. 2002 Feb;38(3):351–376. doi: 10.1016/s0165-0173(01)00160-6. [DOI] [PubMed] [Google Scholar]

Articles from Biochemical Journal are provided here courtesy of The Biochemical Society

RESOURCES